The PharmTech Group editors present our most popular technical articles from 2024.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Pharmaceutical Technology® and Pharmaceutical Technology® Europe publishes independent, science-based articles and peer-reviewed papers from bio/pharmaceutical professionals working in the development and manufacturing of pharmaceuticals. In 2024, Pharmaceutical Technology® and Pharmaceutical Technology® Europe, via print issues, ebooks, and our website, PharmTech.com, published articles on topics ranging from development challenges, to manufacturing best practices, quality considerations, analytical approaches, and more.
The following are our picks for the ‘best of’ technical and peer-reviewed articles published in 2024, in no particular order:
For more peer-reviewed articles, please visit https://www.pharmtech.com/topic/peer-reviewed-research.
For the latest on drug development, please visit https://www.pharmtech.com/topic/drug-development.
To read in-depth manufacturing articles, visit https://www.pharmtech.com/topic/manufacturing.
A variety of quality-related topics can be found at https://www.pharmtech.com/topic/quality-gmps.
And the latest analytical technologies are discussed at https://www.pharmtech.com/topic/analytics.
For information on how to submit technical and peer-reviewed articles to Pharmaceutical Technology®, please view our submission guidelines at https://www.pharmtech.com/view/pharmaceutical-technology-submission-guidelines-and-editorial-calendars.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.